Publications by authors named "E S Kozhemyakina"

We previously found that FoxA factors are necessary for chondrocyte differentiation. To investigate whether FoxA factors alone are sufficient to drive chondrocyte hypertrophy, we build a FoxA2 transgenic mouse in which FoxA2 cDNA is driven by a reiterated Tetracycline Response Element (TRE) and a minimal CMV promoter. This transgenic line was crossed with a col2CRE;Rosa26 mouse line to generate col2CRE;Rosa26;TgFoxA2 mice for inducible expression of FoxA2 in cartilage using doxycycline treatment.

View Article and Find Full Text PDF

During endochondral bone formation, chondrocyte hypertrophy represents a crucial turning point from chondrocyte differentiation to bone formation. Both parathyroid hormone-related protein (PTHrP) and histone deacetylase 4 (HDAC4) inhibit chondrocyte hypertrophy. Using multiple mouse genetics models, we demonstrate in vivo that HDAC4 is required for the effects of PTHrP on chondrocyte differentiation.

View Article and Find Full Text PDF
Article Synopsis
  • RAX is an important protein that helps develop eyes and the brain in animals, and when it's not working right in mice, they can be born without eyes and have other serious problems.
  • In a specific case, a child was found to have eye issues, a rare hormone problem, and a cleft lip and palate because of a severe mutation in the RAX gene.
  • This child's genetic issue was worse than others previously reported, suggesting that the strong mutation caused their serious health problems, matching closely with issues seen in mice with similar RAX mutations.
View Article and Find Full Text PDF

Aim: To study the relationship of the initial clinical and functional state of patients with arterial hypertension (AH) with the dynamics of daily indices of blood pressure (BP) and sinus rhythm on antihypertensive therapy.

Materials And Methods: 38 patients were examined (general clinical examination, electrocardiography, echocardiography, daily bifunctional monitoring with the determination of weighted average rhythmogram variations - WARV, clinical and biochemical analysis of blood, glycated hemoglobin, thyroid hormones) and distribyted according to the use of hypotensive drugs of main classes and combined therapy AH. Dynamic monitoring of the effectiveness of treatment was carried out (after 2-4 weeks, then every 1-2 months), clinically and with bifunctional monitoring, correction of therapy.

View Article and Find Full Text PDF

Aim: To evaluate the diagnostic utility of long-term remote monitoring of ECG compared with 24 hour Holter monitoring for the detection of cardiac arrhythmias and conduction disturbance in patients with atrial fibrillation (AF) after catheter radiofrequency ablation (RFA; isolation) of the pulmonary veins.

Materials And Methods: The study included 62 patients aged 58.5±11.

View Article and Find Full Text PDF